These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 8750190)

  • 1. Gene therapeutic approach to primary and metastatic brain tumors: I. CD44 variant pre-RNA alternative splicing as a CEPT control element.
    Asman DC; Dirks JF; Ge L; Resnick NM; Salvucci LA; Gau JT; Becich MJ; Cooper DL; Dougherty GJ
    J Neurooncol; 1995 Dec; 26(3):243-50. PubMed ID: 8750190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential expressions of CD44 variants in tumors affecting the central nervous system.
    Resnick DK; Resnick NM; Welch WC; Cooper DL
    Mol Diagn; 1999 Sep; 4(3):219-32. PubMed ID: 10553022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alternative splicing of CD44 pre-mRNA in human colorectal tumors.
    Finn L; Dougherty G; Finley G; Meisler A; Becich M; Cooper DL
    Biochem Biophys Res Commun; 1994 Apr; 200(2):1015-22. PubMed ID: 7513991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multisite and bidirectional exonic splicing enhancer in CD44 alternative exon v3.
    Vela E; Hilari JM; Roca X; Muñoz-Mármol AM; Ariza A; Isamat M
    RNA; 2007 Dec; 13(12):2312-23. PubMed ID: 17940137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chondroitin sulphate composition and structure in alternatively spliced CD44 fusion proteins.
    Piepkorn M; Hovingh P; Bennett KL; Aruffo A; Linker A
    Biochem J; 1997 Oct; 327 ( Pt 2)(Pt 2):499-506. PubMed ID: 9359422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A first step in the development of gene therapy for colorectal carcinoma: cloning, sequencing, and expression of Escherichia coli cytosine deaminase.
    Austin EA; Huber BE
    Mol Pharmacol; 1993 Mar; 43(3):380-7. PubMed ID: 8450832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of intron length on alternative splicing of CD44.
    Bell MV; Cowper AE; Lefranc MP; Bell JI; Screaton GR
    Mol Cell Biol; 1998 Oct; 18(10):5930-41. PubMed ID: 9742110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD44 isoform expression in periodontal tissues: cell-type specific regulation of alternative splicing.
    Hirano F; Hirano H; Hino E; Takayama S; Saito K; Kusumoto Y; Shimabukuro Y; Murakami S; Okada H
    J Periodontal Res; 1997 Nov; 32(8):634-45. PubMed ID: 9409458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of CD44 splice variants in human primary brain tumors.
    Kaaijk P; Troost D; Morsink F; Keehnen RM; Leenstra S; Bosch DA; Pals ST
    J Neurooncol; 1995 Dec; 26(3):185-90. PubMed ID: 8750184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular mechanisms regulating the tumor-targeting potential of splice-activated gene expression.
    Hayes GM; Dougherty ST; Davis PD; Dougherty GJ
    Cancer Gene Ther; 2004 Dec; 11(12):797-807. PubMed ID: 15359288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SR proteins regulate V6 exon splicing of CD44 pre-mRNA.
    Loh TJ; Moon H; Jang HN; Liu Y; Choi N; Shen S; Williams DR; Jung DW; Zheng X; Shen H
    BMB Rep; 2016 Nov; 49(11):612-616. PubMed ID: 27530682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new alternatively spliced exon between v9 and v10 provides a molecular basis for synthesis of soluble CD44.
    Yu Q; Toole BP
    J Biol Chem; 1996 Aug; 271(34):20603-7. PubMed ID: 8702806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD44 expression patterns in breast and colon tumors: a PCR-based study of splice variants.
    Rodriguez C; Monges G; Rouanet P; Dutrillaux B; Lefrançois D; Theillet C
    Int J Cancer; 1995 Oct; 64(5):347-54. PubMed ID: 7591309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SC35 promotes splicing of the C5-V6-C6 isoform of CD44 pre-mRNA.
    Loh TJ; Moon H; Cho S; Jung DW; Hong SE; Kim DH; Green MR; Zheng X; Zhou J; Shen H
    Oncol Rep; 2014 Jan; 31(1):273-9. PubMed ID: 24173428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trans-acting factors regulate the expression of CD44 splice variants.
    Konig H; Moll J; Ponta H; Herrlich P
    EMBO J; 1996 Aug; 15(15):4030-9. PubMed ID: 8670907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The p53-induced RNA-binding protein ZMAT3 is a splicing regulator that inhibits the splicing of oncogenic CD44 variants in colorectal carcinoma.
    Muys BR; Anastasakis DG; Claypool D; Pongor L; Li XL; Grammatikakis I; Liu M; Wang X; Prasanth KV; Aladjem MI; Lal A; Hafner M
    Genes Dev; 2021 Jan; 35(1-2):102-116. PubMed ID: 33334821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteoglycan forms of the lymphocyte homing receptor CD44 are alternatively spliced variants containing the v3 exon.
    Jackson DG; Bell JI; Dickinson R; Timans J; Shields J; Whittle N
    J Cell Biol; 1995 Feb; 128(4):673-85. PubMed ID: 7532175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD44 isoforms containing exon V3 are responsible for the presentation of heparin-binding growth factor.
    Bennett KL; Jackson DG; Simon JC; Tanczos E; Peach R; Modrell B; Stamenkovic I; Plowman G; Aruffo A
    J Cell Biol; 1995 Feb; 128(4):687-98. PubMed ID: 7532176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Arrayed primer extension computing with variant mRNA splice forms. Multiple isoforms of CD44 in a human breast tumor.
    Kim H; Pirrung MC
    J Am Chem Soc; 2002 May; 124(18):4934-5. PubMed ID: 11982338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple intron retention occurs in tumor cell CD44 mRNA processing.
    Goodison S; Yoshida K; Churchman M; Tarin D
    Am J Pathol; 1998 Oct; 153(4):1221-8. PubMed ID: 9777953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.